Optos Plc Stock Rating Reaffirmed by N+1 Singer (OPTS)
Optos Plc (LON:OPTS)‘s stock had its “buy” rating reaffirmed by research analysts at N+1 Singer in a report released on Thursday. They currently have a GBX 260 ($4.45) price objective on the stock. N+1 Singer’s price target indicates a potential upside of 41.12% from the company’s current price.
OPTS has been the subject of a number of other recent research reports. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Optos Plc in a research note on Thursday, May 15th. They now have a GBX 300 ($5.14) price target on the stock. Separately, analysts at Investec reiterated a “reduce” rating on shares of Optos Plc in a research note on Thursday, May 15th. Finally, analysts at Shore Capital reiterated a “buy” rating on shares of Optos Plc in a research note on Tuesday, May 13th. One investment analyst has rated the stock with a sell rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of GBX 252.67 ($4.33).
Optos Plc (LON:OPTS) traded up 6.29% on Thursday, hitting GBX 186.00. 28,204 shares of the company’s stock traded hands. Optos Plc has a 1-year low of GBX 143.976 and a 1-year high of GBX 214.50. The stock’s 50-day moving average is GBX 177.8 and its 200-day moving average is GBX 184.1. The company’s market cap is £134.5 million.
Optos Plc is a retinal imaging company. The Company’s medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina in a single capture.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.